Want to track 0R1F and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
0R1F earnings report is expected in 65 days (30 Apr 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
 | | 1.44 | - |
| | | 1.2 | 0.53 |
| | | 1.52 | 1.08 |
| | | 1.13 | 0.64 |
| | | - | - |
| | | - | 0.04 |
| | | - | 0.6 |
| | | - | 0.83 |
| | | - | - |
| | | - | 0.87 |
| | | - | 0.93 |
0R1F Earnings Reports FAQ
What is the earnings per share (EPS) for 0R1F?
EPS data for 0R1F is currently not available, as Bristol-Myers Squibb Company has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 2 years, the earnings growth rate has been approximately -24.49%, reflecting the 0R1F's performance and LSE market conditions.
When is the next earnings release date?
The next earnings release is expected to be on 2026-04-30, based on the 0R1F's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings were 0.5326 per share, reported on 2026-02-05. For dividend history, visit the 0R1F Dividends page.
What is the price-to-earnings (P/E) ratio?
The price-to-earnings (P/E) ratio is 115.19, calculated based on the most recent stock price of $61.35.
